China Resources Jiangzhong Pharmaceutical Co.,Ltd
Shanghai Stock ExchangeTotal Valuation
China Resources Jiangzhong Pharmaceutical Co.,Ltd carries a market capitalization of 15.11B, placing it among publicly traded companies globally. Its enterprise value stands at 16.50B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 15.11B |
| Enterprise Value | 16.50B |
Share Statistics
China Resources Jiangzhong Pharmaceutical Co.,Ltd currently has 635.61M shares outstanding.
| Shares Outstanding | 635.61M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
China Resources Jiangzhong Pharmaceutical Co.,Ltd trades at a trailing price-to-earnings ratio of 22.35. The price-to-sales ratio is 5.10, and the price-to-book ratio stands at 4.70.
| PE Ratio | 22.35 |
| PS Ratio | 5.10 |
| PB Ratio | 4.70 |
| P/TBV Ratio | 3.68 |
| P/FCF Ratio | 88.76 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, China Resources Jiangzhong Pharmaceutical Co.,Ltd trades at an EV/EBITDA multiple of 17.96 and an EV/FCF ratio of 86.83. The EV/Sales ratio of 5.03 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.96 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.03 |
| EV / EBITDA | 17.96 |
| EV / EBIT | 17.96 |
| EV / FCF | 86.83 |
Financial Position
China Resources Jiangzhong Pharmaceutical Co.,Ltd maintains a current ratio of 1.86, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.04, indicating conservative leverage, while an interest coverage ratio of 492.68 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.86 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | 492.68 |
Financial Efficiency
China Resources Jiangzhong Pharmaceutical Co.,Ltd posts a return on equity of 21.50 and a return on invested capital of 14.90.
| Return on Equity (ROE) | 21.50 |
| Return on Assets (ROA) | 10.82 |
| Return on Invested Capital (ROIC) | 14.90 |
| Return on Capital Employed (ROCE) | 16.60 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.72 |
Taxes
Over the trailing twelve months, China Resources Jiangzhong Pharmaceutical Co.,Ltd has paid 184.23M in income taxes, reflecting an effective tax rate of 18.54.
| Income Tax | 184.23M |
| Effective Tax Rate | 18.54 |
Stock Price Statistics
China Resources Jiangzhong Pharmaceutical Co.,Ltd's stock has gained approximately 8.5884% over the past 52 weeks. The 50-day moving average sits at 24.04, while the 200-day moving average is 23.87.
| Beta (5Y) | N/A |
| 52-Week Price Change | 8.5884% |
| 50-Day Moving Average | 24.04 |
| 200-Day Moving Average | 23.87 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, China Resources Jiangzhong Pharmaceutical Co.,Ltd generated 3.28B in revenue and converted that into 748.70M in net income, yielding earnings per share of 1.29. EBITDA reached 918.60M, while operating income came in at 918.60M.
| Revenue | 3.28B |
| Gross Profit | 2.14B |
| Operating Income | 918.60M |
| Pretax Income | 993.76M |
| Net Income | 748.70M |
| EBITDA | 918.60M |
| EBIT | 918.60M |
| Earnings Per Share (EPS) | 1.29 |
Balance Sheet
China Resources Jiangzhong Pharmaceutical Co.,Ltd holds 938.47M in cash and equivalents against 1.82M in total debt, resulting in a net debt position of -838.38M. Total book value stands at 3.56B, with working capital of 1.60B providing operational flexibility.
| Cash & Cash Equivalents | 938.47M |
| Total Debt | 1.82M |
| Net Debt | -838.38M |
| Equity (Book Value) | 3.56B |
| Book Value Per Share | 5.69 |
| Working Capital | 1.60B |
Cash Flow
After subtracting -188.50M in capital expenditures, free cash flow totaled -188.50M - equivalent to -0.30 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -188.50M |
| Free Cash Flow | -188.50M |
| FCF Per Share | -0.30 |
Margins
China Resources Jiangzhong Pharmaceutical Co.,Ltd operates with a gross margin of 65.40, reflecting its pricing power and cost economics. The operating margin of 28.01 and net profit margin of 22.83 provide insight into operational efficiency.
| Gross Margin | 65.40 |
| Operating Margin | 28.01 |
| Pretax Margin | 30.30 |
| Profit Margin | 22.83 |
| EBITDA Margin | 28.01 |
Dividends & Yields
The company's payout ratio of 36.48 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.51 |
| Dividend Yield | N/A |
| Payout Ratio | 36.48 |
| Shareholder Yield | 2.84 |
| FCF Yield | 1.13 |
Stock Splits
China Resources Jiangzhong Pharmaceutical Co.,Ltd's most recent stock split took place on June 12, 2020 with a 5:6 split ratio.
| Last Split Date | 6/12/2020 |
| Split Ratio | 5:6 |
Scores
China Resources Jiangzhong Pharmaceutical Co.,Ltd posts an Altman Z-Score of 6.54, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.54 |